Alpha 2.0
Login Register
» Authors » Ivan Sloma

Ivan Sloma

Explore the profile of Ivan Sloma including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 34
Citations 240
Followers 0
Related Specialties
Hematology
Oncology
Allergy & Immunology
Top 10 Co-Authors
Orianne Wagner-Ballon
Violaine Tran Quang
Sihem Tarfi
Sebastien Maury
Connie J Eaves
Ali G Turhan
Bouchra Badaoui
Dominique Charron
Lydia Roy
Annelise Bennaceur-Griscelli
Published In
Haematologica
Hum Immunol
Leuk Lymphoma
Am J Hematol
Exp Hematol
Affiliations
Soon will be listed here.
Recent Articles
1.
Detection of clinically relevant variants in the gene below 10% allelic frequency: A multicenter study by ERIC, the European Research Initiative on CLL
Pavlova S, Malcikova J, Radova L, Bonfiglio S, Cowland J, Brieghel C, et al.
Hemasphere . 2025 Jan; 9(1):e70065. PMID: 39840379
In chronic lymphocytic leukemia, the reliability of next-generation sequencing (NGS) to detect variants ≤10% allelic frequency (low-VAF) is debated. We tested the ability to detect 23 such variants in 41...
2.
Mutation of Epigenetic Regulators at Diagnosis Is an Independent Predictor of Tyrosine Kinase Inhibitor Treatment Failure in Chronic Myeloid Leukemia: A Report From the RESIDIAG Study
Guerineau H, Cayuela J, Dulucq S, Tran Quang V, Tarfi S, Gricourt G, et al.
Am J Hematol . 2024 Dec; 100(3):507-510. PMID: 39654506
No abstract available.
3.
Predicting which subsets of patients with myelodysplastic neoplasms are more likely to progress to overt chronic myelomonocytic leukemia
Tran Quang V, Wagner-Ballon O, Sloma I
Leuk Lymphoma . 2024 Jul; 65(12):1766-1776. PMID: 39004904
The boundary between myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML) has been revised in the latest World Health Organization classification of myeloid malignancies. These changes were motivated by the...
4.
Audet J, Berger M, Cashman J, Chalandon Y, Coulombel L, Flamant S, et al.
Bull Cancer . 2024 May; PMID: 38760290
No abstract available.
5.
Long-term outcome after autologous -negative peripheral blood stem cell transplantation in adults with Philadelphia-positive acute lymphoblastic leukemia: a comparative study
Caillot L, Leclerc M, Sleiman E, Sloma I, Wagner-Ballon O, Claudel A, et al.
Haematologica . 2023 Nov; 109(4):1264-1268. PMID: 38031800
No abstract available.
6.
mutational status affects myelodysplastic syndrome evolution to chronic myelomonocytic leukemia
Tran Quang V, Podvin B, Desterke C, Tarfi S, Barathon Q, Badaoui B, et al.
Haematologica . 2023 Apr; 108(11):3135-3141. PMID: 37102610
No abstract available.
7.
Effective use of intensive treatment against multiple myeloma of recipient origin after allogeneic transplantation for acute myeloid leukemia
de Charry F, Konopacki J, Bugier S, Foissaud V, Sloma I, Malfuson J, et al.
Leuk Res Rep . 2023 Apr; 19:100366. PMID: 37006953
We describe here a 56-years -old woman cured in our institution for an acute myeloid leukemia (AML) and a monoclonal gammopathy of undetermined significance (MGUS). In order to treat AML,...
8.
ABO blood barrier to engraftment after allogeneic stem cell transplantation in sickle cell disease: A case-story with two successive HLA-matched sibling donors
Redjoul R, Beckerich F, De Luna G, Leclerc M, Hebert N, Sloma I, et al.
Am J Hematol . 2022 Dec; 98(4):692-696. PMID: 36510370
No abstract available.
9.
Evaluation of two new highly multiplexed PCR assays as an alternative to next-generation sequencing for IDH1/2 mutation detection
Favre L, Sako N, Tarfi S, Tran Quang V, Joy C, Dupuy A, et al.
Mol Oncol . 2022 Sep; 16(22):3916-3926. PMID: 36062346
IDH1 and IDH2 somatic mutations have been identified in solid tumors and blood malignancies. The development of inhibitors of mutant IDH1 and IDH2 in the past few years has prompted...
10.
[Myeloid neoplasms associated with rearrangement of PDGFRB: A rare and tricky disease]
Bontoux C, Badaoui B, Abermil N, Tarfi S, Guermouche H, Dubois S, et al.
Ann Pathol . 2022 Sep; 42(6):481-487. PMID: 36050197
In the latest World Health Organization classification (WHO), eosinophilic disorders represent a group of rare pathologic conditions with highly heterogeneous pathophysiology. In this report, we describe a case of myeloid...